<html>
<head>PUBMED IDs for TTC5</head>
<body bgcolor='#C5F0F2'><h1>TTC5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9559292/'>Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction.</a> April 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11267936/'>The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.</a> March 27  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12210830/'>Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.</a> September 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14662021/'>Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine.</a> December 10  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/20043111/'>Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.</a> March 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20043111/'>Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.</a> March 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23559008/'>TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.</a> August 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24091941/'>Human TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway.</a> June 12  2013<br></body></html>
